Global Flu Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022


Report ID : RNR-196427 Category : Medical Devices Published Date : 8/28/2017
Publisher : GlobalInfo Research Pages : 122 Format : PDF
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:
This report focuses on the Flu Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    CSL
    GSK
    Sanofi Pasteur
    Mylan
    AstraZeneca
    Pfizer
    Johnson & Johnson

Market Segment by Regions, regional analysis covers
    North America (USA, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Columbia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Vaccines
    Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

There are 15 Chapters to deeply display the global Flu Vaccine market.

Chapter 1, to describe Flu Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Flu Vaccine, with sales, revenue, and price of Flu Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1 Market Overview
    1.1 Flu Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Whole Virus Vaccines
        1.2.2 Split Virus Vaccines
        1.2.3 Subunit Vaccines
        1.2.4 Live Attenuated Virus Vaccines
    1.3 Market Analysis by Applications
        1.3.1 For Children (6 months to 3 years)
        1.3.2 For Adults and Children over 3 years
    1.4 Market Analysis by Regions
        1.4.1 North America (USA, Canada and Mexico)
            1.4.1.1 USA Market States and Outlook (2012-2022)
            1.4.1.2 Canada Market States and Outlook (2012-2022)
            1.4.1.3 Mexico Market States and Outlook (2012-2022)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2012-2022)
            1.4.2.2 France Market States and Outlook (2012-2022)
            1.4.2.3 UK Market States and Outlook (2012-2022)
            1.4.2.4 Russia Market States and Outlook (2012-2022)
            1.4.2.5 Italy Market States and Outlook (2012-2022)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2012-2022)
            1.4.3.2 Japan Market States and Outlook (2012-2022)
            1.4.3.3 Korea Market States and Outlook (2012-2022)
            1.4.3.4 India Market States and Outlook (2012-2022)
            1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2012-2022)
            1.4.4.2 Egypt Market States and Outlook (2012-2022)
            1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
            1.4.4.4 South Africa Market States and Outlook (2012-2022)
            1.4.4.5 Nigeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 CSL
        2.1.1 Business Overview
        2.1.2 Flu Vaccine Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 GSK
        2.2.1 Business Overview
        2.2.2 Flu Vaccine Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Sanofi Pasteur
        2.3.1 Business Overview
        2.3.2 Flu Vaccine Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Mylan
        2.4.1 Business Overview
        2.4.2 Flu Vaccine Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 AstraZeneca
        2.5.1 Business Overview
        2.5.2 Flu Vaccine Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Pfizer
        2.6.1 Business Overview
        2.6.2 Flu Vaccine Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Johnson & Johnson
        2.7.1 Business Overview
        2.7.2 Flu Vaccine Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Flu Vaccine Market Competition, by Manufacturer
    3.1 Global Flu Vaccine Sales and Market Share by Manufacturer
    3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer
    3.3 Market Concentration Rate
        3.3.1 Top 3 Flu Vaccine Manufacturer Market Share
        3.3.2 Top 6 Flu Vaccine Manufacturer Market Share
    3.4 Market Competition Trend
4 Global Flu Vaccine Market Analysis by Regions
    4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions
        4.1.1 Global Flu Vaccine Sales by Regions (2012-2017)
        4.1.2 Global Flu Vaccine Revenue by Regions (2012-2017)
    4.2 North America Flu Vaccine Sales and Growth (2012-2017)
    4.3 Europe Flu Vaccine Sales and Growth (2012-2017)
    4.4 Asia-Pacific Flu Vaccine Sales and Growth (2012-2017)
    4.5 South America Flu Vaccine Sales and Growth (2012-2017)
    4.6 Middle East and Africa Flu Vaccine Sales and Growth (2012-2017)
5 North America Flu Vaccine by Countries
    5.1 North America Flu Vaccine Sales, Revenue and Market Share by Countries
        5.1.1 North America Flu Vaccine Sales by Countries (2012-2017)
        5.1.2 North America Flu Vaccine Revenue by Countries (2012-2017)
    5.2 USA Flu Vaccine Sales and Growth (2012-2017)
    5.3 Canada Flu Vaccine Sales and Growth (2012-2017)
    5.4 Mexico Flu Vaccine Sales and Growth (2012-2017)
6 Europe Flu Vaccine by Countries
    6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Countries
        6.1.1 Europe Flu Vaccine Sales by Countries (2012-2017)
        6.1.2 Europe Flu Vaccine Revenue by Countries (2012-2017)
    6.2 Germany Flu Vaccine Sales and Growth (2012-2017)
    6.3 UK Flu Vaccine Sales and Growth (2012-2017)
    6.4 France Flu Vaccine Sales and Growth (2012-2017)
    6.5 Russia Flu Vaccine Sales and Growth (2012-2017)
    6.6 Italy Flu Vaccine Sales and Growth (2012-2017)
7 Asia-Pacific Flu Vaccine by Countries
    7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Flu Vaccine Sales by Countries (2012-2017)
        7.1.2 Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017)
    7.2 China Flu Vaccine Sales and Growth (2012-2017)
    7.3 Japan Flu Vaccine Sales and Growth (2012-2017)
    7.4 Korea Flu Vaccine Sales and Growth (2012-2017)
    7.5 India Flu Vaccine Sales and Growth (2012-2017)
    7.6 Southeast Asia Flu Vaccine Sales and Growth (2012-2017)
8 South America Flu Vaccine by Countries
    8.1 South America Flu Vaccine Sales, Revenue and Market Share by Countries
        8.1.1 South America Flu Vaccine Sales by Countries (2012-2017)
        8.1.2 South America Flu Vaccine Revenue by Countries (2012-2017)
    8.2 Brazil Flu Vaccine Sales and Growth (2012-2017)
    8.3 Argentina Flu Vaccine Sales and Growth (2012-2017)
    8.4 Columbia Flu Vaccine Sales and Growth (2012-2017)
9 Middle East and Africa Flu Vaccine by Countries
    9.1 Middle East and Africa Flu Vaccine Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Flu Vaccine Sales by Countries (2012-2017)
        9.1.2 Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017)
    9.2 Saudi Arabia Flu Vaccine Sales and Growth (2012-2017)
    9.3 UAE Flu Vaccine Sales and Growth (2012-2017)
    9.4 Egypt Flu Vaccine Sales and Growth (2012-2017)
    9.5 Nigeria Flu Vaccine Sales and Growth (2012-2017)
    9.6 South Africa Flu Vaccine Sales and Growth (2012-2017)
10 Global Flu Vaccine Market Segment by Type
    10.1 Global Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017)
        10.1.1 Global Flu Vaccine Sales and Market Share by Type (2012-2017)
        10.1.2 Global Flu Vaccine Revenue and Market Share by Type (2012-2017)
    10.2 Whole Virus Vaccines Sales Growth and Price
        10.2.1 Global Whole Virus Vaccines Sales Growth (2012-2017)
        10.2.2 Global Whole Virus Vaccines Price (2012-2017)
    10.3 Split Virus Vaccines Sales Growth and Price
        10.3.1 Global Split Virus Vaccines Sales Growth (2012-2017)
        10.3.2 Global Split Virus Vaccines Price (2012-2017)
    10.4 Subunit Vaccines Sales Growth and Price
        10.4.1 Global Subunit Vaccines Sales Growth (2012-2017)
        10.4.2 Global Subunit Vaccines Price (2012-2017)
    10.5 Live Attenuated Virus Vaccines Sales Growth and Price
        10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2012-2017)
        10.5.2 Global Live Attenuated Virus Vaccines Price (2012-2017)
11 Global Flu Vaccine Market Segment by Application
    11.1 Global Flu Vaccine Sales Market Share by Application (2012-2017)
    11.2 For Children (6 months to 3 years) Sales Growth (2012-2017)
    11.3 For Adults and Children over 3 years Sales Growth (2012-2017)
12 Flu Vaccine Market Forecast (2017-2022)
    12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
    12.2 Flu Vaccine Market Forecast by Regions (2017-2022)
        12.2.1 North America Flu Vaccine Market Forecast (2017-2022)
        12.2.2 Europe Flu Vaccine Market Forecast (2017-2022)
        12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2017-2022)
        12.2.4 South America Flu Vaccine Market Forecast (2017-2022)
        12.2.5 Middle East and Africa Flu Vaccine Market Forecast (2017-2022)
    12.3 Flu Vaccine Market Forecast by Type (2017-2022)
    12.4 Flu Vaccine Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source